Compare TKO Group Holdings Inc (TKO) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TKO Group Holdings Inc vs TransMedics Group Inc — how do they compare? TKO Group Holdings Inc trades at $181.83 (market cap $13.70B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: TKO Group Holdings Inc is far larger — about 5.4× TransMedics Group Inc's market cap, and TKO Group Holdings Inc pays a 1.7% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| TKO | TMDX | |
|---|---|---|
Market Cap | $13.70B | $2.54B |
Sector | Technology | Technology |
52-Week High | $224.96 | $150.42 |
52-Week Low | $155.61 | $61.99 |
Enterprise Value | $17.88B | $2.94B |
Dividend Yield | 1.7% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TKO Group Holdings Inc
TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
